Omni-Stat (Chitosan) arrests bleeding in heparinised subjects in vivo: an experimental study in a model of major peripheral vascular injury

Eur J Cardiothorac Surg. 2011 Jun;39(6):952-4. doi: 10.1016/j.ejcts.2010.09.037. Epub 2010 Nov 4.

Abstract

Objective: To explore the effectiveness of Omni-Stat (Chitosan) in a model of major haemorrhage in the presence of clotting dysfunction.

Method: A total of 12 major femoral artery bleeds in moderately heparinised swine treated with Omni-Stat (Chitosan) were compared with five control bleeds.

Results: Haemostasis was successfully achieved at first treatment in 10 of 12 bleeds and at second treatment in the remaining two bleeds.

Conclusion: The study supports the evidence that Omni-Stat (Chitosan) acts independently of classical clotting pathways and should be effective in patients with clotting dysfunctions, who suffer major haemorrhage. It also suggests the potential for a role in cardiac surgery.

MeSH terms

  • Animals
  • Anticoagulants / toxicity
  • Chitosan / therapeutic use*
  • Disease Models, Animal
  • Drug Evaluation, Preclinical / methods
  • Female
  • Femoral Artery / injuries*
  • Hemorrhage / chemically induced
  • Hemorrhage / drug therapy*
  • Hemorrhage / etiology
  • Hemostatic Techniques
  • Hemostatics / therapeutic use*
  • Heparin / toxicity
  • Male
  • Sus scrofa
  • Vascular System Injuries / complications*

Substances

  • Anticoagulants
  • Hemostatics
  • Heparin
  • Chitosan